Invesco Ltd. Ikena Oncology, Inc. Transaction History
Invesco Ltd.
- $600 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding IKNA
# of Institutions
6Shares Held
2.57MCall Options Held
0Put Options Held
0-
Chi Advisors LLC New York, NY2.18MShares$3.01 Million4.65% of portfolio
-
Black Rock Inc. New York, NY355KShares$489,6810.0% of portfolio
-
Oup Management Co., LLC26.8KShares$37,0290.26% of portfolio
-
Baystate Wealth Management LLC3KShares$4,1380.0% of portfolio
-
Private Capital Group, LLC252Shares$3470.0% of portfolio
About Ikena Oncology, Inc.
- Ticker IKNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,257,500
- Market Cap $50M
- Description
- Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...